Tempest Therapeutics (TPST) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.62, -1.70% vs the prior close of $0.63.
- Volume 67.11K shares, 0.0x its 50-day average (light).
- New SEC filings: PRE 14A (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
TPST dips 1.7% to $0.62, a 52-week low, 7 down days in a row. Closed at $0.62, -1.70% vs the prior close of $0.63. Day range $0.62–$0.67, opened at $0.67.
TPST daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — TPST dips 1.7% to $0.62, a 52-week low, 7 down days in a row
- Closed at $0.62, -1.70% vs the prior close of $0.63. Day range $0.62–$0.67, opened at $0.67.
- Volume was 67.11K shares, 0.0x its 50-day average of 3.27M — lighter than usual.
- Price is -32.8% vs its 50-day average ($0.93) and -61.4% vs its 200-day average ($1.62).
- 52-week range $0.62–$11.98; today's close sits at 0% of that range, 94.8% below the 52-week high.
- That makes 7 straight losses.
Oct 15, 2026 — TPST ends flat (+0.0%) to $0.63, 6 down days in a row
- Closed at $0.63, +0.00% vs the prior close of $0.63. Day range $0.62–$0.65, opened at $0.63.
- Volume was 120.80K shares, 0.0x its 50-day average of 3.27M — lighter than usual.
- Price is -32.0% vs its 50-day average ($0.93) and -61.0% vs its 200-day average ($1.63).
- 52-week range $0.62–$12.23; today's close sits at 0% of that range, 94.8% below the 52-week high.
- That makes 6 straight losses.
Oct 14, 2026 — TPST slides 6.8% to $0.63, a 52-week low, 5 down days in a row
- Closed at $0.63, -6.75% vs the prior close of $0.68. Day range $0.63–$0.70, opened at $0.70.
- Volume was 179.10K shares, 0.1x its 50-day average of 3.27M — lighter than usual.
- Price is -32.4% vs its 50-day average ($0.94) and -61.3% vs its 200-day average ($1.64).
- 52-week range $0.63–$12.23; today's close sits at 0% of that range, 94.8% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — TPST slides 8.3% to $0.68, a 52-week low, 4 down days in a row
- Closed at $0.68, -8.34% vs the prior close of $0.74. Day range $0.68–$0.75, opened at $0.75.
- Volume was 228.70K shares, 0.1x its 50-day average of 3.26M — lighter than usual.
- Price is -27.9% vs its 50-day average ($0.94) and -58.8% vs its 200-day average ($1.65).
- 52-week range $0.68–$12.23; today's close sits at 0% of that range, 94.4% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — TPST dips 2.2% to $0.74, a 52-week low, 3 down days in a row
- Closed at $0.74, -2.24% vs the prior close of $0.76. Day range $0.74–$0.78, opened at $0.76.
- Volume was 163.60K shares, 0.1x its 50-day average of 3.26M — lighter than usual.
- Price is -21.7% vs its 50-day average ($0.95) and -55.4% vs its 200-day average ($1.66).
- 52-week range $0.74–$12.23; today's close sits at 0% of that range, 93.9% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — TPST dips 1.3% to $0.76
- Closed at $0.76, -1.30% vs the prior close of $0.77. Day range $0.76–$0.81, opened at $0.78.
- Volume was 180.10K shares, 0.1x its 50-day average of 3.26M — lighter than usual.
- Price is -20.1% vs its 50-day average ($0.95) and -54.7% vs its 200-day average ($1.68).
- 52-week range $0.74–$12.23; today's close sits at 0% of that range, 93.8% below the 52-week high.
Oct 8, 2026 — TPST dips 2.7% to $0.77
- Closed at $0.77, -2.65% vs the prior close of $0.79. Day range $0.76–$0.80, opened at $0.79.
- Volume was 147.10K shares, 0.0x its 50-day average of 3.26M — lighter than usual.
- Price is -19.2% vs its 50-day average ($0.95) and -54.4% vs its 200-day average ($1.69).
- 52-week range $0.74–$12.23; today's close sits at 0% of that range, 93.7% below the 52-week high.
Oct 7, 2026 — TPST rises 0.4% to $0.79
- Closed at $0.79, +0.38% vs the prior close of $0.79. Day range $0.75–$0.82, opened at $0.79.
- Volume was 307.40K shares, 0.1x its 50-day average of 3.26M — lighter than usual.
- Price is -17.2% vs its 50-day average ($0.96) and -53.5% vs its 200-day average ($1.70).
- 52-week range $0.74–$12.23; today's close sits at 0% of that range, 93.5% below the 52-week high.
Oct 6, 2026 — TPST dips 0.6% to $0.79
- Closed at $0.79, -0.63% vs the prior close of $0.79. Day range $0.77–$0.80, opened at $0.79.
- Volume was 217.60K shares, 0.1x its 50-day average of 3.25M — lighter than usual.
- Price is -17.7% vs its 50-day average ($0.96) and -53.9% vs its 200-day average ($1.71).
- 52-week range $0.74–$12.23; today's close sits at 0% of that range, 93.6% below the 52-week high.
Oct 5, 2026 — TPST dips 2.2% to $0.79
- Closed at $0.79, -2.22% vs the prior close of $0.81. Day range $0.78–$0.82, opened at $0.80.
- Volume was 155.20K shares, 0.0x its 50-day average of 3.26M — lighter than usual.
- Price is -17.4% vs its 50-day average ($0.96) and -53.9% vs its 200-day average ($1.72).
- 52-week range $0.74–$12.23; today's close sits at 0% of that range, 93.5% below the 52-week high.
Oct 2, 2026 — TPST rises 0.6% to $0.81
- Closed at $0.81, +0.62% vs the prior close of $0.81. Day range $0.78–$0.85, opened at $0.82.
- Volume was 2.27M shares, 0.7x its 50-day average of 3.22M.
- Price is -15.7% vs its 50-day average ($0.96) and -53.2% vs its 200-day average ($1.73).
- 52-week range $0.74–$12.23; today's close sits at 1% of that range, 93.4% below the 52-week high.
TPST latest news & SEC filings
Every SEC filing by or about TPST in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 2, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 25, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 16, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
- Item 8.01 — Reported other events the company considers important.
Sep 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Sep 1, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 31, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 27, 2026 · Form CORRESP — Company letter to the SEC
Company letter to the SEC
Things to know before you trade TPST
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 30, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.17% (largest 29.2%). That is a volatile stock.
- Liquidity: about 594.60K shares (≈$371.15K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.62 vs a range of $0.62–$11.98 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:13 on Apr 9, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: Matthew Angel bought 231,482 shares on Mar 24, 2026.
- Latest filings: 8-K Sep 28, 2026; 8-K Sep 17, 2026; 8-K Sep 16, 2026.
- Share count: 14.81M shares outstanding (May 8, 2026), +302.1% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
TPST market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.67 | 0.67 | 0.62 | 0.62 | 67.11K |
| Oct 15, 2026 | 0.63 | 0.65 | 0.62 | 0.63 | 120.80K |
| Oct 14, 2026 | 0.70 | 0.70 | 0.63 | 0.63 | 179.10K |
| Oct 13, 2026 | 0.75 | 0.75 | 0.68 | 0.68 | 228.70K |
| Oct 12, 2026 | 0.76 | 0.78 | 0.74 | 0.74 | 163.60K |
| Oct 9, 2026 | 0.78 | 0.81 | 0.76 | 0.76 | 180.10K |
| Oct 8, 2026 | 0.79 | 0.80 | 0.76 | 0.77 | 147.10K |
| Oct 7, 2026 | 0.79 | 0.82 | 0.75 | 0.79 | 307.40K |
| Oct 6, 2026 | 0.79 | 0.80 | 0.77 | 0.79 | 217.60K |
| Oct 5, 2026 | 0.80 | 0.82 | 0.78 | 0.79 | 155.20K |
| Oct 2, 2026 | 0.82 | 0.85 | 0.78 | 0.81 | 2.27M |
| Oct 1, 2026 | 0.81 | 0.83 | 0.80 | 0.81 | 153.40K |
| Sep 30, 2026 | 0.81 | 0.84 | 0.80 | 0.83 | 265.00K |
| Sep 29, 2026 | 0.83 | 0.85 | 0.80 | 0.81 | 152.30K |
| Sep 28, 2026 | 0.82 | 0.85 | 0.80 | 0.83 | 256.40K |
| Sep 25, 2026 | 0.87 | 0.89 | 0.81 | 0.83 | 285.80K |
| Sep 24, 2026 | 0.90 | 0.92 | 0.85 | 0.85 | 442.40K |
| Sep 23, 2026 | 0.99 | 1.01 | 0.90 | 0.92 | 787.20K |
| Sep 22, 2026 | 0.78 | 1.09 | 0.77 | 1.00 | 3.61M |
| Sep 21, 2026 | 0.92 | 0.94 | 0.76 | 0.77 | 1.90M |
About Tempest Therapeutics
Tempest Therapeutics (TPST) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BRISBANE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1544227.
TPST board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Matthew Angel | CEO and President | Jun 23, 2026 |
| Geoffrey Nichol | Director | Jan 28, 2026 |
| Christine A Pellizzari | Director | Jan 28, 2026 |
| Michael Raab | Director | Jan 28, 2026 |
| William Drake Richey | Director | Jun 8, 2026 |
| Ronit Simantov | Director | Jan 28, 2026 |
| John D. Yee | Director | Jun 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Matthew Angel | CEO and President | Jun 23, 2026 |
| Nicholas Maestas | Chief Financial Officer | Apr 2, 2026 |
| Justin Trojanowski | Corporate Controller | Apr 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 24, 2026 | Matthew Angel | Buy | 231,482 | $2.16 |
| Mar 24, 2026 | Matthew Angel | Buy | 231,482 | $2.16 |
| Mar 24, 2026 | Matthew Angel | Buy | 231,482 | $2.16 |
| Mar 24, 2026 | Matthew Angel | Buy | 231,482 | $2.16 |
| Mar 24, 2026 | Matthew Angel | Buy | 231,482 | $2.16 |
| Mar 24, 2026 | Matthew Angel | Buy | 231,482 | $2.16 |
| Mar 24, 2026 | Matthew Angel | Buy | 231,482 | $2.16 |
| Mar 24, 2026 | Matthew Angel | Buy | 231,482 | $2.16 |
TPST financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-26.26M | -6.33 | $-26.82M |
| Dec 31, 2024 | — | $-41.84M | -19.50 | $-33.03M |
| Dec 31, 2023 | — | $-29.49M | -1.91 | $-27.36M |
| Dec 31, 2022 | — | $-35.71M | -3.09 | $-31.07M |
| Dec 31, 2021 | — | $-28.30M | -7.47 | $-25.96M |
Latest balance sheet: total assets $9.63M, total liabilities $10.72M, cash $779.00K (as of Jun 30, 2026).
TPST earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $1.17 |
| May 14, 2026 | 8-K Item 2.02 (results) | $2.09 |
| Mar 30, 2026 | 8-K Item 2.02 (results) | $1.52 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $9.95 |
| Aug 11, 2025 | 8-K Item 2.02 (results) | $8.01 |
| May 13, 2025 | 8-K Item 2.02 (results) | $6.79 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $10.92 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $14.04 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 19, 2024 | 8-K Item 2.02 (results) | — |
| Nov 8, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on TPST
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.